Adial Pharmaceuticals Inc
ADIL
Get informed when a big investor buys or sells
+ FollowMarket Cap$4.66M
Close$
$8.80
109.4% upside
Current Fair Value
109.4% upsideUndervalued by 109.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $4.66 Million |
|---|---|
| Enterprise Value | $-24,048,130.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-11.93 |
| Beta | 1.39 |
| Outstanding Shares | 4,621,735 |
Return
| Return on Equity | 150.61% |
|---|---|
| Return on Assets | -198.70% |
| Return on Invested Capital | -240.64% |
Valuation & Multiples
| P/E Ratio | -0.29 |
|---|---|
| PEG | -0.01 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 0.42 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 14, 2026
EPS Estimate
$-1.03
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
November 18, 2026
EPS Estimate
$-0.17
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 18.69%▲ 16.09% |
|---|---|
| Total Invested | $1.92M▲ 2906.98% |
| Investors Holding | 18▲ 3.00% |
ESG Score
No data
About Adial Pharmaceuticals Inc
2,018 employees